Clobetasol Propionate Foam — Class II drug recall D-0374-2022
Terminated recall by Ingenus Pharmaceuticals Llc, reported 2022-01-26, distributed nationwide. CGMP Deviations
| Recall number | D-0374-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ingenus Pharmaceuticals Llc, Orlando, FL, United States |
| Recall initiated | 2022-01-10 |
| Classified | 2022-01-14 |
| Reported by FDA | 2022-01-26 |
| Terminated | 2023-08-15 |
| Distributed | Nationwide (US) |
| Quantity | 45,173 cans |
| Reason classes | cgmp |
| NDC | 50742-0304-01, 50742-0304-50 |
| Lot numbers | 32921, 33152, 33340 |
| Expiration dates | 2022-06, 2022-08, 2022-11 |
Product
Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC 50742-304-01), Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC, Orlando, FL 32839-6408.
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0374-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.